Survey of Pregabalin augmentation in patients with chronic post traumatic stress disorder
Not Applicable
- Conditions
- chronic Post-traumatic stress disorder( PTSD).Post-traumatic stress disorder
- Registration Number
- IRCT201302145280N12
- Lead Sponsor
- Mashhad University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Male
- Target Recruitment
- 38
Inclusion Criteria
diagnose with PTSD based on DSM-IV-TR criteria, age between 30 and 65 years, had no significant cognitive disorder and no history of drug abuse except for nicotine.
Exclusion criteria: were unwillingness of patients to continue the trial; active medical disease, other diseases in axis one or two except for PTSD and sensitivity to Pregabalin.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Post traumatic stress disorder. Timepoint: 0, 2, 4 and 6th weeks. Method of measurement: PCL test.
- Secondary Outcome Measures
Name Time Method Quality of life. Timepoint: 0, 2, 4 and 6th weeks. Method of measurement: Spitzer Quality of Life index( SQL).;Depression. Timepoint: 0, 2, 4 and 6th weeks. Method of measurement: Hamilton Depression Rating Scale.;Anxiety. Timepoint: 0, 2, 4 and 6th weeks. Method of measurement: Hamilton Anxiety Rating Scale.